# Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours

> **NCT01692379** · PHASE3 · TERMINATED · sponsor: **Fundacio Ictus Malaltia Vascular** · enrollment: 206 (actual)

## Conditions studied

- Acute Stroke

## Interventions

- **DEVICE:** Solitaire FR device
- **OTHER:** Medical treatment

## Key facts

- **NCT ID:** NCT01692379
- **Lead sponsor:** Fundacio Ictus Malaltia Vascular
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-12
- **Target enrollment:** 206 (ACTUAL)
- **Why stopped:** Following DSMB advice after first interim analysis (n=174)
- **Last updated:** 2016-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01692379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01692379, "Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01692379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*